General Information
Version
8.0
Revision date
2023-04-10
Product name
Liothyronine sodium impurity standard, British Pharmacopoeia (BP) Reference Standard
REACH No
This
Emergency telephone
+(46)-852503403
Icons in SDS
Company Information
company name
Merck Life Science AB
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H361fd, H372
Hazard statements
Code
Statements
H361fd
Suspected of damaging fertility. Suspected of damaging the unborn child.
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. H372 Causes damage to organs (Thyroid, Cardio-vascular system, Kidney) through prolonged or repeated exposure. H372 Causes damage to organs through prolonged or repeated exposure. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Reproductive toxicity (Category 2), H361fd Specific target organ toxicity - repeated exposure (Category 1), Thyroid, Cardio-vascular system, Kidney, H372 For the full text of the H-Statements mentioned in this Section, see Section 16.
